Autopsy report · NCT00925093

Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection

“Primary investigator left institution”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Aarhus University Hospital

Sponsor type

University, hospital or other

Conditions

Neurosurgery

Interventions

Vancomycin; Teicoplanin; Linezolid

Participants

0

Trials that died the same way

• Effectiveness of Transverse Abdominus Plane Catheter Blocks to Patient-controlled Analgesia in Laparoscopic Colon Resections
  “Investigator Left Institution” (94% match in meaning)
• Prepectoral vs Partial Subpectoral Two-Stage Implant-Based Breast Reconstruction
  “Principal Investigator left institution” (92% match in meaning)
• Intralesional Tetracycline Injection in the Treatment of Chalazia
  “Investigator left the institution” (89% match in meaning)
• Opioid Induced Loss of Local Anesthetic Potency in Patients Undergoing Total Knee Arthroplasty
  “Responsible Investigator left institution” (88% match in meaning)
• Use of Cast Iron Pots to Improve Maternal Anemia
  “Original investigator has left the institution.” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.